- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07453264
Effect of Thermoregulation Bundle Applied at Birth on Neonatal Physiological Parameters and Breastfeeding
May 3, 2026 updated by: yeşim dilki, Istanbul University - Cerrahpasa
Effect of Thermoregulation Bundle Applied at Birth on Neonatal Physiological Parameters and Breastfeeding: A Randomized Controlled Trial
Maintaining neonatal body temperature (thermoregulation), particularly during the first hour after birth, is critical for survival and successful adaptation to the extrauterine environment.
Implementation of a thermoregulation bundle is expected to facilitate faster stabilization of physiological parameters and to positively influence the initiation of breastfeeding as well as overall breastfeeding success.
The effects of a thermoregulation bundle applied at birth on neonatal physiological parameters-including body temperature, respiratory rate, heart rate, and oxygen saturation-and on breastfeeding outcomes will be evaluated.
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
Thermoregulation in Newborns and the Care Bundle ApproachThermoregulation is the ability to maintain body temperature within specific ranges despite changes in ambient temperature.
Maintaining the newborn's body temperature, particularly within the first hour after birth, is critical for survival and adaptation to the external environment.
When thermoregulation cannot be achieved during this first hour-often referred to as the "Golden Hour"-it can lead to adverse outcomes such as hypothermia, hypoglycemia, respiratory distress, and delayed breastfeeding.
Preventing neonatal hypothermia in the delivery room stands out as a cost-effective approach to reducing neonatal mortality.Maintaining a stable body temperature is challenging for newborns.
They are at high risk for hypothermia due to weak subcutaneous fat tissue, a high body surface area-to-weight ratio, and the immaturity of the nervous and cardiovascular systems involved in heat production.
Subcutaneous fat constitutes 2-6% of a newborn's body weight, and they utilize this tissue to maintain thermal balance.
Because their surface area-to-weight ratio is significantly higher than that of adults, newborns lose heat four times faster.
Hypothermia is an independent risk factor that affects multiple systems and increases neonatal morbidity and mortality.
Thermoregulation, which is vital in neonatal care, ensures the maintenance of normal body temperature by balancing heat production and heat loss.
The normal body temperature for newborns should be maintained between 36.5°C and 37.5°C.
To optimize this, the WHO recommends that delivery rooms be kept between 25°C and 28°C (77°F-82.4°F).
Maintaining the room temperature within the recommended range is of vital importance, as the newborn increases oxygen and energy consumption when unable to keep body temperature within normal limits.To prevent hypothermia and support breastfeeding in healthy newborns, the WHO recommends skin-to-skin contact with the mother for the first hour after birth and dressing the baby appropriately for the ambient temperature.
This typically means using twice as many layers as an adult, including a hat .
The Turkish Neonatology Society's delivery room management guidelines prioritize heating and drying over positioning the head and aspiration.
In newborns, a body temperature of $<36.0°C$ is considered hypothermia, while $>38°C$ is considered hyperthermia.
According to the World Health Organization's recommendations, the temperature in the delivery room should be between 23-25°C.
For term infants, the guidelines suggest drying the baby with warm, dry linens starting from the head, removing wet linens immediately, and placing a hat that covers the ears.
Healthy term infants should be placed in skin-to-skin contact on the mother's chest, facing her, with their backs covered by a warm blanket.
Unless respiratory support is required, these infants do not need to be placed under a radiant warmer.
If respiratory support is provided, ensuring the air is humidified and heated is crucial for preventing hypothermia.
The use of radiant warmers for term and preterm infants born with moderate-to-severe hypoxic-ischemic encephalopathy should be carefully evaluated.
Furthermore, the Turkish Neonatology Society explicitly states that hot water bottles, surgical gloves filled with hot water, or bags should never be used to warm the baby, as they may cause burns .In a study examining the success of thermoregulation on breastfeeding, it was observed that newborns' body temperatures increased during the nursing process.
In the experimental group, infants were breastfed in a room at 22-25°C with reduced clothing (only a bodysuit and diaper), while the control group breastfed in the same room temperature with their existing clothes.
The study found that newborns in the experimental group (reduced clothing) breastfed for longer durations on the first day.
Interventions to support thermoregulation have been shown to prevent both neonatal hypothermia and hyperthermia.
Procedures performed in the first hours after birth must be carried out with correct timing and sequence to support thermal regulation .
In the literature, there is a lack of studies examining the effects of a "Thermoregulation Bundle" specifically for term infants.
A "Care Bundle" approach involves the simultaneous and complete application of a small set of evidence-based interventions (usually 3-5) that have been scientifically proven to improve patient outcomes.
These bundles are typically applied following an "all-or-nothing" rule; if one element is missed, the entire bundle is considered incomplete .
A thermoregulation bundle is a cost-effective approach that ensures evidence-based and standardized thermal care after birth.
The results obtained from this research are expected to provide evidence for interventions aimed at maintaining newborn temperature in the delivery room, thereby supporting neonatal health and successful breastfeeding.
Study Type
Interventional
Enrollment (Estimated)
140
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: yeşim dilki, student
- Phone Number: +905010732834
- Email: yesimdilki@ogr.iuc.edu.tr
Study Contact Backup
- Name: gülçin bozkurt, Professor Doctor
- Phone Number: +905336349093
- Email: gbozkurt@iuc.edu.tr
Study Locations
-
-
darıca
-
Kocaeli, darıca, Turkey (Türkiye), 41000
- Recruiting
- Kocaeli Darıca Farabi Eğitim Ve Araştırma Hastanesi
-
Contact:
- yeşim dilki, student
- Phone Number: +905010732834
- Email: yesimdilki@ogr.iuc.edu.tr
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- The baby is born vaginally
- It is a singleton pregnancy,
- The baby is born at term (gestational age 38-42 weeks),
- The baby's Apgar score is ≥ 7 at 1 minute,
- The baby's birth weight is between 2500-4000 grams,
- The baby is exclusively breastfed,
- The baby has no problems preventing breastfeeding,
- The mother has no problems preventing breastfeeding,
- There are no maternal or fetal complications.
Exclusion Criteria:
- The baby being preterm/postterm,
- Starting formula feeding,
- The baby having special care needs (intensive care, etc.),
- The baby having intrauterine growth restriction (IUGR), genetic disease, etc.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: THERMOREGULATION BUNDLE GROUP
Newborns in this group will receive a Thermoregulation Package immediately after birth. The package includes the following:
|
A structured set of evidence-based thermal care interventions applied immediately after birth, including maintaining appropriate delivery room temperature, immediate drying with warm linens, removal of wet towels, application of a hat, early skin-to-skin contact for the first hour, and covering the newborn with a warm blanket.
The bundle is implemented using an all-or-nothing approach.
|
|
Other: CONTROL GROUP
Newborns in this group will receive routine delivery room care according to the standard hospital protocol.
No structured thermoregulation bundle will be applied.
|
Standard delivery room care according to institutional protocol.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
neonatal body temperature stability
Time Frame: with in first 60 minutes postpartum
|
Body temperature (°C) of the newborn measured at 1, 5, 30, and 60 minutes after birth.
|
with in first 60 minutes postpartum
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
time to first breastfeeding
Time Frame: within first 1 hours postpartum
|
The time (in minutes) from birth to the first successful latch
|
within first 1 hours postpartum
|
|
Early Breastfeeding Success
Time Frame: Within the first 1 hours postpartum
|
Breastfeeding success assessed using the LATCH breastfeeding assessment tool.
|
Within the first 1 hours postpartum
|
|
incidence of neonatal hypothermia
Time Frame: Within the first 60 minutes after birth
|
The proportion of newborns with axillary temperature <36.5°C.
|
Within the first 60 minutes after birth
|
|
Apgar score
Time Frame: At 1 and 5 minutes after birth
|
Assessed at 1 and 5 minutes after birth using the Apgar scoring system (range: 0-10).
Higher scores indicate better neonatal condition.
|
At 1 and 5 minutes after birth
|
|
Oxygen saturation (SpO₂)
Time Frame: Within the first 60 minutes after birth
|
Peripheral oxygen saturation (%) measured at 1, 5, 30, and 60 minutes after birth.
|
Within the first 60 minutes after birth
|
|
Heart rate
Time Frame: Within the first 60 minutes after birth
|
Heart rate (beats per minute) measured at 1, 5, 30, and 60 minutes after birth.
|
Within the first 60 minutes after birth
|
|
Respiratory rate
Time Frame: Within the first 60 minutes after birth
|
Respiratory rate (breaths per minute) measured at 1, 5, 30, and 60 minutes after birth.
|
Within the first 60 minutes after birth
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: gülçin bozkurt, Professor Doctor, istanbul üniversitesi cerrahpaşa sağlık bilimleri fakültesi
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2025
Primary Completion (Actual)
March 30, 2026
Study Completion (Estimated)
August 30, 2026
Study Registration Dates
First Submitted
March 2, 2026
First Submitted That Met QC Criteria
March 2, 2026
First Posted (Actual)
March 5, 2026
Study Record Updates
Last Update Posted (Actual)
May 5, 2026
Last Update Submitted That Met QC Criteria
May 3, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IstanbulUC-SBF-YD-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The study can be shared by the researcher once it is completed.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neonatal Adaptation
-
Universidad Nacional de ColombiaCompleted
-
University Medical Centre LjubljanaRecruitingNeonatal AdaptationSlovenia
-
Medical University of GrazCompleted
-
Pamukkale UniversityCompletedGynecologic Cancer | Chemotherapy Effect | Mobile Application | Physiological Adaptation | Psychosocial AdaptationTurkey
-
University of ZurichUnknown
-
University of CopenhagenCompleted
-
Hacettepe UniversityCompleted
-
PepsiCo Global R&DTerminatedSweetness Liking AdaptationUnited States
-
Amsterdam UMC, location VUmcDutch Cancer SocietyTerminatedAdaptation, EmotionalNetherlands
-
University of Nove de JulhoFundação de Amparo à Pesquisa do Estado de São PauloCompleted
Clinical Trials on Thermoregulation bundle
-
University of Alabama at BirminghamChildren's Health System, AlabamaWithdrawn
-
Instituto Mexicano del Seguro SocialCompleted
-
Virginia Polytechnic Institute and State UniversityNational Cancer Institute (NCI); University of MinnesotaCompletedCigarette SmokingUnited States
-
Oslo University HospitalCompleted
-
Children's Hospital Medical Center, CincinnatiChildren's Hospital of Philadelphia; Agency for Healthcare Research and Quality...Active, not recruitingCardiopulmonary Resuscitation | In-hospital Cardiac ArrestUnited States
-
Children's Hospital of PhiladelphiaEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingInfant | Intubation ComplicationUnited States, Canada
-
Tampere University HospitalCompleted
-
Peking University Third HospitalUnknownRupture of Anterior Cruciate Ligament
-
University Medical Centre LjubljanaRecruitingBundle-Branch Block | AV Block | Atrial Fibrillation RapidSlovenia
-
Weill Medical College of Cornell UniversityCTI BioPharmaCompletedMyelodysplastic SyndromeUnited States